股来股去
日常观察和经验总结
感谢一位网友的推荐。虽然最近金盆洗手，不想玩太speculative的股票，这个Rhythm Phar 还是非常有意思的。对于胆子肥的可以看看。也许到了18-19$，我又破戒买一点也说不定。
行业：（ZT）
Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic disorders. The company's lead product candidate is setmelanotide, a melanocortin-4 receptor, which is in Phase III clinical trials to treat pro-opiomelanocortin (POMC) and leptin receptor deficiency obesity, and Bardet-Biedl and Alström syndrome; and is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. It is also developing RM-853, an orally available ghrelin o-acyltransferase inhibitor that is in preclinical development for Prader-Willi syndrome.
资金情况：cash 240 米， free cash flow -80 米，应该可以撑一下。
pipeline：见上面。专业人士请多评论。
TA：感觉这一波下跌差不多了。RSI，Stoch 都到了上次底部的级别，STO 有拐头的迹象，觉得到20以下应该可以慢慢吃一点。估计不会跌过18。
YMYD。
